235
Views
23
CrossRef citations to date
0
Altmetric
Review

Peptides and proteins used to enhance gold nanoparticle delivery to the brain: preclinical approaches

, , , , , & show all
Pages 4919-4936 | Published online: 10 Aug 2015

References

  • HirschLRStaffordRJBanksonJANanoshell-mediated near-infrared thermal therapy of tumors under magnetic resonance guidanceProc Natl Acad Sci U S A200310023135491355414597719
  • AduraCGuerreroSSalasEStable conjugates of peptides with gold nanorods for biomedical applications with reduced effects on cell viabilityACS Appl Mater Interfaces20135104076408523597259
  • KoganMJOlmedoIHostaLGuerreroARCruzLJAlbericioFPeptides and metallic nanoparticles for biomedical applicationsNanomedicine20072328730617716175
  • KohlerNSunCWangJZhangMMethotrexate-modified super-paramagnetic nanoparticles and their intracellular uptake into human cancer cellsLangmuir200521198858886416142971
  • KoganMJBastusNGAmigoRNanoparticle-mediated local and remote manipulation of protein aggregationNano Lett20066111011516402797
  • ArayaEOlmedoIBastusNGold nanoparticles and microwave irradiation inhibit beta-amyloid amyloidogenesisNanoscale Res Lett2008311435443
  • KrolSChallenges in drug delivery to the brain: nature is against usJ Control Release2012164214515522609350
  • Ai TranHNSousaFModaFA novel class of potential prion drugs: preliminary in vitro and in vivo data for multilayer coated gold nanoparticlesNanoscale20102122724273220944860
  • SousaFMandalSGarrovoCFunctionalized gold nanoparticles: a detailed in vivo multimodal microscopic brain distribution studyNanoscale20102122826283420949211
  • TriulziRCDaiQZouJPhotothermal ablation of amyloid aggregates by gold nanoparticlesColloids Surf B Biointerfaces200863220020818262396
  • WangYTLuXMZhuFThe use of a gold nanoparticle-based adjuvant to improve the therapeutic efficacy of hNgR-Fc protein immunization in spinal cord-injured ratsBiomaterials201132317988799821784510
  • ChienCCChengCCChenHHX-ray microscopy and tomography detect the accumulation of bare and PEG-coated gold nanoparticles in normal and tumor mouse tissuesAnal Bioanal Chem201240451287129622918568
  • YangXSkrabalakSELiZYXiaYWangLVPhotoacoustic tomography of a rat cerebral cortex in vivo with au nanocages as an optical contrast agentNano Lett20077123798380218020475
  • LuWHuangQKuGPhotoacoustic imaging of living mouse brain vasculature using hollow gold nanospheresBiomaterials20103192617262620036000
  • WangPHLiuHLHsuPHGold-nanorod contrast-enhanced photoacoustic micro-imaging of focused-ultrasound induced blood-brain-barrier opening in a rat modelJ Biomed Opt201217606122222734752
  • EtheridgeMLCampbellSAErdmanAGHaynesCLWolfSMMcCulloughJThe big picture on nanomedicine: the state of investigational and approved nanomedicine productsNanomedicine20139111422684017
  • LibuttiSKPaciottiGFByrnesAAPhase I and pharmacokinetic studies of CYT-6091, a novel PEGylated colloidal gold-rhTNF nano-medicineClin Cancer Res201016246139614920876255
  • BeckerNHNovikoffABZimmermanHMFine structure observations of the uptake of intravenously injected peroxidase by the rat choroid plexusJ Histochem Cytochem19671531601656034514
  • NabeshimaSReeseTSLandisDMBrightmanMWJunctions in the meninges and marginal gliaJ Comp Neurol19751642127169810497
  • ReeseTSKarnovskyMJFine structural localization of a blood-brain barrier to exogenous peroxidaseJ Cell Biol19673412072176033532
  • AbbottNJComparative physiology of the blood-brain barrierBradburyMBPhysiology and Pharmacology of the Blood-Brain Barrier103BerlinSpringer1992371396
  • AbbottNJPatabendigeAADolmanDEYusofSRBegleyDJStructure and function of the blood-brain barrierNeurobiol Dis2010371132519664713
  • MaeMArmulikABetsholtzCGetting to know the cast – cellular interactions and signaling at the neurovascular unitCurr Pharm Des201117262750275421827409
  • NagSMorphology and properties of brain endothelial cellsMethods Mol Biol201168634721082365
  • MathiisenTMLehreKPDanboltNCOttersenOPThe perivascular astroglial sheath provides a complete covering of the brain microvessels: an electron microscopic 3D reconstructionGlia20105891094110320468051
  • NagelhusEAOttersenOPPhysiological roles of aquaporin-4 in brainPhysiol Rev20139341543156224137016
  • IliffJJWangMLiaoYA paravascular pathway facilitates CSF flow through the brain parenchyma and the clearance of interstitial solutes, including amyloid betaSci Transl Med20124147147ra111
  • NedergaardMNeuroscience. Garbage truck of the brainScience201334061401529153023812703
  • VerkhratskyANedergaardMHertzLWhy are astrocytes important?Neurochem Res201540238940125113122
  • IliffJJWangMZeppenfeldDMCerebral arterial pulsation drives paravascular CSF-interstitial fluid exchange in the murine brainJ Neurosci20133346181901819924227727
  • XieLKangHXuQSleep drives metabolite clearance from the adult brainScience2013342615637337724136970
  • PujalsSFernandez-CarneadoJLopez-IglesiasCKoganMJGiraltEMechanistic aspects of CPP-mediated intracellular drug delivery: relevance of CPP self-assemblyBiochim Biophys Acta20061758326427916545772
  • DeguchiYNaitoTYugeTBlood-brain barrier transport of 125I-labeled basic fibroblast growth factorPharm Res2000171636910714610
  • DeguchiYMiyakawaYSakuradaSBlood-brain barrier transport of a novel micro 1-specific opioid peptide, H-Tyr-D-Arg-Phe-beta-Ala-OH (TAPA)J Neurochem20038451154116112603838
  • HerveFGhineaNScherrmannJMCNS delivery via adsorptive transcytosisAAPS J200810345547218726697
  • PardridgeWMDrug and gene targeting to the brain via blood-brain barrier receptor-mediated transport systemsInt Congr Ser2005127704962
  • PardridgeWMDrug targeting to the brainPharm Res20072491733174417554607
  • GabathulerRApproaches to transport therapeutic drugs across the blood-brain barrier to treat brain diseasesNeurobiol Dis2010371485719664710
  • DeclevesXJacobAYousifSShawahnaRPotinSScherrmannJMInterplay of drug metabolizing CYP450 enzymes and ABC transporters in the blood-brain barrierCurr Drug Metab201112873274121623707
  • VassKHickeyWFSchmidtRELassmannHBone marrow-derived elements in the peripheral nervous system. An immunohistochemical and ultrastructural investigation in chimeric ratsLab Invest19936932752828377470
  • Gonzalez-ScaranoFMartin-GarciaJThe neuropathogenesis of AIDSNat Rev Immunol200551698115630430
  • DeanMAllikmetsRComplete characterization of the human ABC gene familyJ Bioenerg Biomembr200133647547911804189
  • ChooEFLeakeBWandelCPharmacological inhibition of P-glycoprotein transport enhances the distribution of HIV-1 protease inhibitors into brain and testesDrug Metab Dispos200028665566010820137
  • AlyautdinRKhalinINafeezaMIHaronMHKuznetsovDNanoscale drug delivery systems and the blood-brain barrierInt J Nanomedicine2014979581124550672
  • BatrakovaEVMillerDWLiSAlakhovVYKabanovAVElmquistWFPluronic P85 enhances the delivery of digoxin to the brain: in vitro and in vivo studiesJ Pharmacol Exp Ther2001296255155711160643
  • ZhangXAlakhovaDYBatrakovaEVEffect of pluronic p85 on amino acid transport in bovine brain microvessel endothelial cellsJ Neuroimmune Pharmacol200941354618677571
  • BatrakovaEVLiSLiYAlakhovVYKabanovAVEffect of pluronic P85 on ATPase activity of drug efflux transportersPharm Res200421122226223315648254
  • BatrakovaEVLiSVinogradovSVAlakhovVYMillerDWKabanovAVMechanism of pluronic effect on P-glycoprotein efflux system in blood-brain barrier: contributions of energy depletion and membrane fluidizationJ Pharmacol Exp Ther2001299248349311602658
  • BilskyEJEgletonRDMitchellSAEnkephalin glycopeptide analogues produce analgesia with reduced dependence liabilityJ Med Chem200043132586259010891118
  • EgletonRDMitchellSAHuberJDImproved bioavailability to the brain of glycosylated Met-enkephalin analogsBrain Res20008811374611033091
  • MorrisMCDeshayesSHeitzFDivitaGCell-penetrating peptides: from molecular mechanisms to therapeuticsBiol Cell2008100420121718341479
  • MagerIEiriksdottirELangelKEl AndaloussiSLangelUAssessing the uptake kinetics and internalization mechanisms of cell-penetrating peptides using a quenched fluorescence assayBiochim Biophys Acta20101798333834319909725
  • FuAHuiEKLuJZBoadoRJPardridgeWMNeuroprotection in stroke in the mouse with intravenous erythropoietin-Trojan horse fusion proteinBrain Res2011136920320721047502
  • TamaruMAkitaHKajimotoKSatoYHatakeyamaHHarashimaHAn apolipoprotein E modified liposomal nanoparticle: ligand dependent efficiency as a siRNA delivery carrier for mouse-derived brain endothelial cellsInt J Pharm20144651–2778224530390
  • ZorkoMLangelUCell-penetrating peptides: mechanism and kinetics of cargo deliveryAdv Drug Deliv Rev200557452954515722162
  • KumagaiAKEisenbergJBPardridgeWMAbsorptive-mediated endocytosis of cationized albumin and a beta-endorphin-cationized albumin chimeric peptide by isolated brain capillaries. Model system of blood-brain barrier transportJ Biol Chem19872623115214152192959663
  • Fernandez-CarneadoJKoganMJCastelSGiraltEPotential peptide carriers: amphipathic proline-rich peptides derived from the N-terminal domain of gammazeinAngew Chem Int Ed Engl200443141811181415054781
  • LalatsaASchatzleinAGUchegbuIFStrategies to deliver peptide drugs to the brainMol Pharm20141141081109324601686
  • RenJShenSWangDThe targeted delivery of anticancer drugs to brain glioma by PEGylated oxidized multi-walled carbon nanotubes modified with angiopep-2Biomaterials201233113324333322281423
  • KuoYCHongTYDelivering etoposide to the brain using catanionic solid lipid nanoparticles with surface 5-HT-modulineInt J Pharm20144651–213214224524828
  • YeYSunYZhaoHA novel lactoferrin-modified beta-cyclodextrin nanocarrier for brain-targeting drug deliveryInt J Pharm2013458111011724126038
  • MalakoutikhahMTeixidoMGiraltEShuttle-mediated drug delivery to the brainAngew Chem Int Ed Engl201150357998801421721080
  • TeixidoMZuritaEMalakoutikhahMTarragoTGiraltEDike-topiperazines as a tool for the study of transport across the blood-brain barrier (BBB) and their potential use as BBB-shuttlesJ Am Chem Soc200712938118021181317764181
  • MalakoutikhahMPradesRTeixidoMGiraltEN-methyl phenylalanine-rich peptides as highly versatile blood-brain barrier shuttlesJ Med Chem20105362354236320170117
  • Lasagna-ReevesCGonzalez-RomeroDBarriaMABioaccumulation and toxicity of gold nanoparticles after repeated administration in miceBiochem Biophys Res Commun2010393464965520153731
  • Semmler-BehnkeMKreylingWGLipkaJBiodistribution of 1.4- and 18-nm gold particles in ratsSmall20084122108211119031432
  • SonavaneGTomodaKMakinoKBiodistribution of colloidal gold nanoparticles after intravenous administration: effect of particle sizeColloids Surf B Biointerfaces200866227428018722754
  • HillyerJFAlbrechtRMCorrelative instrumental neutron activation analysis, light microscopy, transmission electron microscopy, and X-ray microanalysis for qualitative and quantitative detection of colloidal gold spheres in biological specimensMicrosc Microanal1998454814909990870
  • HillyerJFAlbrechtRMGastrointestinal persorption and tissue distribution of differently sized colloidal gold nanoparticlesJ Pharm Sci200190121927193611745751
  • HainfeldJFSlatkinDNFocellaTMSmilowitzHMGold nanoparticles: a new X-ray contrast agentBr J Radiol20067993924825316498039
  • SadauskasEWallinHStoltenbergMKupffer cells are central in the removal of nanoparticles from the organismPart Fibre Toxicol200741017949501
  • De JongWHHagensWIKrystekPBurgerMCSipsAJGeertsmaREParticle size-dependent organ distribution of gold nanoparticles after intravenous administrationBiomaterials200829121912191918242692
  • ChenYSHungYCLinLWLiauIHongMYHuangGSSize-dependent impairment of cognition in mice caused by the injection of gold nanoparticlesNanotechnology2010214848510221051801
  • EtameABDiazRJO’ReillyMAEnhanced delivery of gold nanoparticles with therapeutic potential into the brain using MRI-guided focused ultrasoundNanomedicine2012871133114222349099
  • HainfeldJFSmilowitzHMO’ConnorMJDilmanianFASlatkinDNGold nanoparticle imaging and radiotherapy of brain tumors in miceNanomedicine (Lond)20138101601160923265347
  • LundqvistMStiglerJEliaGLynchICedervallTDawsonKANanoparticle size and surface properties determine the protein corona with possible implications for biological impactsProc Natl Acad Sci U S A200810538142651427018809927
  • Dell’OrcoDLundqvistMOslakovicCCedervallTLinseSModeling the time evolution of the nanoparticle-protein corona in a body fluidPLoS One201056e1094920532175
  • ArvizoRRGiriKMoyanoDIdentifying new therapeutic targets via modulation of protein corona formation by engineered nanoparticlesPLoS One201273e3365022442705
  • MonopoliMPWalczykDCampbellAPhysical-chemical aspects of protein corona: relevance to in vitro and in vivo biological impacts of nanoparticlesJ Am Chem Soc201113382525253421288025
  • TenzerSDocterDRosfaSNanoparticle size is a critical physicochemical determinant of the human blood plasma corona: a comprehensive quantitative proteomic analysisACS Nano2011597155716721866933
  • LundqvistMStiglerJCedervallTThe evolution of the protein corona around nanoparticles: a test studyACS Nano2011597503750921861491
  • DobrovolskaiaMAAggarwalPHallJBMcNeilSEPreclinical studies to understand nanoparticle interaction with the immune system and its potential effects on nanoparticle biodistributionMol Pharm20085448749518510338
  • ReddyJSVenkateswarluVNovel delivery systems for drug targeting to the brainDrugs Future20042916383
  • KreuterJInfluence of the surface properties on nanoparticle-mediated transport of drugs to the brainJ Nanosci Nanotechnol20044548448815503433
  • LacerdaSHParkJJMeuseCInteraction of gold nanoparticles with common human blood proteinsACS Nano20104136537920020753
  • DermietzelRSprayDCNedergaardMFront matter, in blood-brain barriers: from ontogeny to artificial interfacesBlood-Brain Barriers1Weinheim, GermanyWiley-VCH Verlag GmbH & Co. KGaA2007IXXXII
  • KreuterJDrug delivery to the central nervous system by polymeric nanoparticles: what do we know?Adv Drug Deliv Rev20137121423981489
  • Alvarez-LorenzoCSosnikAConcheiroAPEO-PPO block copolymers for passive micellar targeting and overcoming multidrug resistance in cancer therapyCurr Drug Targets20111281112113021443477
  • GaoXWuBZhangQBrain delivery of vasoactive intestinal peptide enhanced with the nanoparticles conjugated with wheat germ agglutinin following intranasal administrationJ Control Release2007121315616717628165
  • GeldenhuysWMbimbaTBuiTHarrisonKSutariyaVBrain-targeted delivery of paclitaxel using glutathione-coated nanoparticles for brain cancersJ Drug Target201119983784521692650
  • HuKShiYJiangWHanJHuangSJiangXLactoferrin conjugated PEG-PLGA nanoparticles for brain delivery: preparation, characterization and efficacy in Parkinson’s diseaseInt J Pharm20114151–227328321651967
  • HuQGuGLiuZF3 peptide-functionalized PEG-PLA nanoparticles co-administrated with tLyp-1 peptide for anti-glioma drug deliveryBiomaterials20133441135114523146434
  • HuangSLiJHanLDual targeting effect of angiopep-2-modified, DNA-loaded nanoparticles for gliomaBiomaterials201132286832683821700333
  • KanazawaTAkiyamaFKakizakiSTakashimaYSetaYDelivery of siRNA to the brain using a combination of nose-to-brain delivery and cell-penetrating peptide-modified nano-micellesBiomaterials201334369220922623992922
  • KeWShaoKHuangRGene delivery targeted to the brain using an angiopep-conjugated polyethyleneglycol-modified polyami-doamine dendrimerBiomaterials200930366976698519765819
  • KimJYChoiWIKimYHTaeGBrain-targeted delivery of protein using chitosan- and RVG peptide-conjugated, pluronic-based nano-carrierBiomaterials20133441170117823122677
  • KuangYAnSGuoYT7 peptide-functionalized nanoparticles utilizing RNA interference for glioma dual targetingInt J Pharm20134541112023867728
  • KuoYCYuHWTransport of saquinavir across human brain-microvascular endothelial cells by poly(lactide-co-glycolide) nanoparticles with surface poly-(gamma-glutamic acid)Int J Pharm2011416136537521736932
  • LiJZhangCLiJBrain delivery of NAP with PEG-PLGA nanoparticles modified with phage display peptidesPharm Res20133071813182323549751
  • LiuLGuoKLuJBiologically active core/shell nanoparticles self-assembled from cholesterol-terminated PEG-TAT for drug delivery across the blood-brain barrierBiomaterials200829101509151718155137
  • LiuLVenkatramanSSYangYYPolymeric micelles anchored with TAT for delivery of antibiotics across the blood-brain barrierBiopolymers200890561762318412128
  • LiuYGuoYAnSTargeting caspase-3 as dual therapeutic benefits by RNAi facilitating brain-targeted nanoparticles in a rat model of Parkinson’s diseasePLoS One201385e6290523675438
  • LiuZGaoXKangTB6 peptide-modified PEG-PLA nanoparticles for enhanced brain delivery of neuroprotective peptideBioconjug Chem2013246997100723718945
  • LiuZJiangMKangTLactoferrin-modified PEG-co-PCL nanoparticles for enhanced brain delivery of NAP peptide following intranasal administrationBiomaterials201334153870388123453061
  • MathewAFukudaTNagaokaYCurcumin loaded-PLGA nanoparticles conjugated with Tet-1 peptide for potential use in Alzheimer’s diseasePLoS One201273e3261622403681
  • SukJSSuhJChoyKLaiSKFuJHanesJGene delivery to differentiated neurotypic cells with RGD and HIV Tat peptide functionalized polymeric nanoparticlesBiomaterials200627295143515016769110
  • TianXHWangZGMengHTat peptide-decorated gelatin-siloxane nanoparticles for delivery of CGRP transgene in treatment of cerebral vasospasmInt J Nanomedicine2013886587623576867
  • TosiGCostantinoLRivasiFTargeting the central nervous system: in vivo experiments with peptide-derivatized nanoparticles loaded with Loperamide and Rhodamine-123J Control Release200712211917651855
  • XinHShaXJiangXZhangWChenLFangXAnti-glioblastoma efficacy and safety of paclitaxel-loading angiopep-conjugated dual targeting PEG-PCL nanoparticlesBiomaterials201233328167817622889488
  • GuerreroSArayaEFiedlerJLImproving the brain delivery of gold nanoparticles by conjugation with an amphipathic peptideNanomedicine20105689791320735225
  • GuerreroSHeranceJRRojasSSynthesis and in vivo evaluation of the biodistribution of a 18F-labeled conjugate gold-nanoparticle-peptide with potential biomedical applicationBioconjug Chem201223339940822284226
  • SotoCSigurdssonEMMorelliLKumarRACastanoEMFrangioneBBeta-sheet breaker peptides inhibit fibrillogenesis in a rat brain model of amyloidosis: implications for Alzheimer’s therapyNat Med1998478228269662374
  • DeaneRWuZZlokovicBVRAGE (yin) versus LRP (yang) balance regulates alzheimer amyloid beta-peptide clearance through transport across the blood-brain barrierStroke20043511 suppl 12628263115459432
  • DeaneRDu YanSSubmamaryanRKRAGE mediates amyloid-beta peptide transport across the blood-brain barrier and accumulation in brainNat Med20039790791312808450
  • PradesRGuerreroSArayaEDelivery of gold nanoparticles to the brain by conjugation with a peptide that recognizes the transferrin receptorBiomaterials201233297194720522795856
  • DayESZhangLThompsonPAVascular-targeted photothermal therapy of an orthotopic murine glioma modelNanomedicine2012781133114822583571
  • WaltersRKraigRPMedintzINanoparticle targeting to neurons in a rat hippocampal slice culture modelASN Neuro20124638339222973864
  • GlatMSkaatHMenkes-CaspiNMargelSSternEAAge-dependent effects of microglial inhibition in vivo on Alzheimer’s disease neuropathology using bioactive-conjugated iron oxide nanoparticlesJ Nanobiotechnology2013113224059692
  • SchulzFLutzDRuscheNGold nanoparticles functionalized with a fragment of the neural cell adhesion molecule L1 stimulate L1-mediated functionsNanoscale2013521106051061724056775
  • WadghiriYZLiJWangJDetection of amyloid plaques targeted by bifunctional USPIO in Alzheimer’s disease transgenic mice using magnetic resonance microimagingPLoS One201382e5709723468919
  • LuWMelanconMPXiongCEffects of photoacoustic imaging and photothermal ablation therapy mediated by targeted hollow gold nanospheres in an orthotopic mouse xenograft model of gliomaCancer Res201171196116612121856744
  • FrigellJGarciaIGomez-VallejoVLlopJPenadesS68Ga-labeled gold glyconanoparticles for exploring blood-brain barrier permeability: preparation, biodistribution studies, and improved brain uptake via neuropeptide conjugationJ Am Chem Soc2014136144945724320878
  • OnoMChengYKimuraHNovel 18F-labeled benzofuran derivatives with improved properties for positron emission tomography (PET) imaging of beta-amyloid plaques in Alzheimer’s brainsJ Med Chem20115482971297921428407
  • SchäfflerMSousaFWenkABlood protein coating of gold nanoparticles as potential tool for organ targetingBiomaterials201435103455346624461938
  • ShiloMMotieiMHanaPPopovtzerRTransport of nanoparticles through the blood-brain barrier for imaging and therapeutic applicationsNanoscale2014642146215224362586
  • RiverosADadlaniKSalasECaballeroLMeloFKoganMJGold nanoparticle-membrane interactions: implications in biomedicineJ Biomater Tissue Eng201331421
  • OlmedoIArayaESanzFHow changes in the sequence of the peptide CLPFFD-NH2 can modify the conjugation and stability of gold nanoparticles and their affinity for beta-amyloid fibrilsBioconjug Chem20081961154116318510352
  • BowerPVLouieEALongJRStaytonPSDrobnyGPSolid-state NMR structural studies of peptides immobilized on gold nanoparticlesLangmuir20052173002300715779977
  • BarthAInfrared spectroscopy of proteinsBiochim Biophys Acta2007176791073110117692815
  • KurouskiDPostiglioneTDeckert-GaudigTDeckertVLednevIKAmide I vibrational mode suppression in surface (SERS) and tip (TERS) enhanced Raman spectra of protein specimensAnalyst201313861665167323330149
  • ArifMKarthigeyanDSiddhantaSKumarGVPNarayanaCKunduTAnalysis of protein acetyltransferase structure-function relation by surface-enhanced Raman scattering (SERS): a tool to screen and char-acterize small molecule modulatorsHakeSBJanzenCJProtein Acetylation981Humana Press2013239261
  • AlamMIBegSSamadAStrategy for effective brain drug deliveryEur J Pharm Sci201040538540320497904
  • GizurarsonSAnatomical and histological factors affecting intranasal drug and vaccine deliveryCurr Drug Deliv20129656658222788696
  • IllumLNasal drug delivery – possibilities, problems and solutionsJ Control Release2003871–318719812618035
  • MistryAStolnikSIllumLNanoparticles for direct nose-to-brain delivery of drugsInt J Pharm2009379114615719555750
  • WolstenholmeGEWKnightJFoundationCTaste and Smell in VertebratesChurchill1970
  • JoshiHMBhumkarDRJoshiKPokharkarVSastryMGold nanoparticles as carriers for efficient transmucosal insulin deliveryLangmuir200622130030516378435
  • HutterEBoridySLabrecqueSMicroglial response to gold nanoparticlesACS Nano2010452595260620329742
  • KozlovskayaLAbou-KaoudMStepenskyDQuantitative analysis of drug delivery to the brain via nasal routeJ Control Release201418913314024997277
  • AroraPSharmaSGargSPermeability issues in nasal drug deliveryDrug Discov Today200271896797512546871
  • FreeseCUboldiCGibsonMIUptake and cytotoxicity of citrate-coated gold nanospheres: comparative studies on human endothelial and epithelial cellsPart Fibre Toxicol201292322759355